[1]
“An open label study on Depression Patient’s Disability Outcomes: Comparative Evaluation of Escitalopram and Amisulpride”, J Nobel Med Coll, vol. 5, no. 2, pp. 37–42, Dec. 2016, doi: 10.3126/jonmc.v5i2.16315.